112566 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Enzyme detection device
#602Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines
#603Genetically encoded FRET-based MMP-9 activity biosensor and use thereof
#604Cosmetic use of salicylic acid derivatives
#605Resonance energy transfer assay with cleavage sequence and spacer
#606Detection of degradative enzymes and biomolecules in bodily fluids
#607Method for diagnosing cancer through detection of deglycosylation of glycoprotein
#608Personalized protease assay to measure protease activity in neoplasms
#609INSECT METALLOPROTEINASE INHIBITORS
#610Compositions and methods related to tauopathy
#611Botulinum neurotoxins with modified light chain specificity and methods for producing same
#612Method of processing liquid biological material
#613RATIOMETRIC ASSAY FOR HYDROLYTIC ENZYME QUANTIFICATION
#614Glycated hexapeptide oxidase and use thereof
#615Methods of generating and screening for lytic chimeric polypeptides
#616IL-1 FAMILY VARIANTS
#617Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides
#618SRM/MRM assay for the insulin receptor protein
#619Methods and devices for diagnosis of particles in biological fluids
#620Mutant protease biosensors with enhanced detection characteristics
#621toxin resistance assay
#622Method for detecting proteases and active infection in biological fluids and tissues
#623Automated method and system for the analysis of total dietary fiber
#624Method for detecting a target analyte that exhibits protease enzyme activity
#625FLUORESCENT PROBE FOR DETECTING ACTIVITY OF CALPAIN
#626PROSTATE SPECIFIC ANTIGEN PROTEOLYTIC ACTIVITY FOR CLINICAL USE
#627Fibrosis biomarker assay
#628Compositions and methods for identifying enzyme and transport protein inhibitors
#629Analysis of amino acid copolymer compositions
#630Botulinum assay with synaptobrevin substrate moiety
#631Lamin A, an activator of longevity/anti-aging SIRT1 protein
#632Mass spectrometric determination of drug resistance
#633METHODS FOR IDENTIFYING PROTEINS AND COMPOUNDS THAT MODULATE THE ACTIVITY OF OTUB1
#634Thyroglobulin quantitation by mass spectroscopy
#635METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1
#636Enzymatic methods and enzymes
#637Methods of measuring ADAMTS 13 activity
#638Separation device for use in the separation, characterization and/or identification of microorganisms
#639Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody
#640Translocation of a polymer through a nanopore
#641Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
#642Quantification of misfolded TNFR2:Fc
#643Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#644BLUE COLLAGENASE ASSAY
#645SRM assay to indicate cancer therapy
#646Methods for separation and characterization of microorganisms using identifier agents
#647Analysis of amino acid copolymer compositions
#648Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#649Assays for determining levels of plasma protease C1 inhibitor
#650Detecting neoplasm
#651Markers for abnormal cells
#652Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
#653N-end rule protease activity indication methods and uses thereof
#654Methods of Determining Cell Mediated Response
#655Pharmaceutical Compositions and Diagnostic Methods for Inflammatory Skin Diseases, Disorders or Conditions
#656Method for the determination of conformation and conformational changes of proteins and of derivatives thereof
#657Immuno-based retargeted endopeptidase activity assays
#658Substrates and Methods for Preparing Samples for Mass Spectrometry
#659MACROCYCLIC COMPOUNDS AND USES THEREOF
#660Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
#661Small molecule inhibitors of MALT1
#662REAL-TIME, SINGLE-STEP BIOASSAY USING NANOPLASMONIC RESONATOR WITH ULTRA-HIGH SENSITIVITY
#663ANALYSIS OF DISULFIDE BONDS
#664Methods and compositions for the treatment of symptoms of prion diseases
#665HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1
#666Inducible reconstitution and real-time quantitative kinetic system for the study of intramembrane enzymes
#667DPP8 and DPP9 peptide inhibitors
#668Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
#669Nanopore stochastic sensing of biomarkers
#670Detecting infection in reduced pressure wound treatment
#671METHOD FOR MEASURING ENDOTOXIN
#672MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#673Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#674Methods of detecting conjugation site-specific and hidden epitope/antigen
#675IRHOM2 INHIBITION FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#676Tripeptide rhodamine compound
#677Protease-based biosensor
#678Methods for the manufacture of proteolytically processed polypeptides
#679FUNCTION AND REGULATION OF ADAMTS-1
#680Peptide library and use thereof
#681Compositions comprising enzyme-cleavable oxycodone prodrug
#682Self-immolative probes for enzyme activity detection
#683Bioinformatics platform for high-throughput identification and quantification of N—glycopeptide
#684SINGLE MOLECULE PROTEIN SEQUENCING
#685Methods, peptides, and biosensors useful for detecting a broad spectrum of bacteria
#686Methods and systems for rapid continuous flow pathogen cell lysis in a microfluidic channel
#687Resonance energy transfer assay with cleavage sequence and spacer
#688Euglobulin-based method for determining the biological activity of defibrotide
#689Identification and quantification of intact glycopeptides in complex samples
#690Enzyme detection device
#691Real-time assay for the detection of botulinum toxin
#692Botulinum toxin assay with improved sensitivity
#693REGULATORS OF MMP-9 AND USES THEREOF
#694Protease detection
#695THE USE OF ENDOTOXIN NEUTRALIZATION AS A BIOMARKER FOR INTESTINAL WALL DAMAGE
#696Fluorescent probe for high-sensitivity pancreatic fluid detection, and method for detecting pancreatic fluid
#697METHOD FOR DETERMINING DISEASE SEVERITY IN TAUOPATHY-RELATED NEURODEGENERATIVE DISORDERS
#698Polypeptide substrate for the detection of von williebrand factor cleaving protease ADAMTS13
#699Fluorescent separase activity sensor
#700AUTOMATED PROTEIN DIGESTION, RECOVERY, AND ANALYSIS
#701MRM-MS SIGNATURE ASSAY
#702METHOD FOR MEASURING GLYCOSYLATED HEMOGLOBIN, MEASUREMENT REAGENT, AND MEASUREMENT KIT
#703Protease assay
#704Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides
#705Protease assay
#706ENZYME ASSAY WITH DUPLICATE FLUOROPHORES
#707Biochemical markers for CVD risk assessment
#708Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#709Method for simultaneously determining multiple coagulation proteases
#710METHOD FOR DETECTING DISEASE BIOMARKERS
#711FLUORESCENT PROTEINS, SPLIT FLUORESCENT PROTEINS, AND THEIR USES
#712Detection of degradative enzymes and biomolecules in bodily fluids
#713Treatment of pulmonary vascular remodeling with neprilysin
#714Method for obtaining peptides
#715Methods for measuring fat digestibility and uses thereof
#716METHOD FOR THE DETERMINATION OF SEQUENCE VARIANTS OF POLYPEPTIDES
#717METHOD FOR SCREENING THERAPEUTIC AND/OR PROPHYLACTIC AGENTS FOR ALZHEIMER'S DISEASE
#718Biochemical markers for neurodegenerative conditions
#719Modulators for Sirt5 and assays for screening same
#720Selective glycosidase inhibitors and uses thereof
#721METHODS, MICROFLUIDIC DEVICES, AND SYSTEMS FOR DETECTION OF AN ACTIVE ENZYMATIC AGENT
#722Stromal stem cells
#723METHOD FOR SCREENING ANTICANCER DRUGS, AND ANTICANCER DRUG THAT INDUCES CELL DEATH AND USES SUBSTANCE THAT INCREASES GRANZYME M ACTIVITY AS ACTIVE INGREDIENT
#724Multi component antibody based detection technology
#725Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry
#726Compositions and methods relating to fusion protein biomarkers
#727Diagnostic chewing gum for pathogens
#728ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANS
#729Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
#730BIOMARKER FOR SELECTING A SUBJECT FOR APPLICATION OF AN ANTI-C-MET ANTIBODY
#731Device for the diagnosis of inflammatory tissues in dental applications
#732Electrochemical detection of proteases using AC voltammetry on nanoelectrode arrays
#733N-end rule protease activity indication methods and uses thereof
#734Co-translational activation of a transcription factor by proteolytic cleavage and methods of use
#735Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#736Clostridium histolyticum enzymes and methods for the use thereof
#737Use of a cysteine protease of plasmodium vivax
#738STERILITY INDICATING BIOLOGICAL COMPOSITIONS, ARTICLES AND METHODS
#739Protease deubiquitinating inhibitor screening
#740HYDROGEL-MEDIATED TISSUE ANALYSIS
#741Method and system for analyzing protein or peptide
#742Composition from lobster hemocyte extracts for detection of lipopolysaccharides, peptidoglycans and 1,3-beta-D-glucans
#743Heterocycle-functionalized luminogens exhibiting aggregation-induced emission
#744ELECTROCHEMICAL ASSAY FOR THE DETECTION OF ENZYMES
#745Methods for treatment of bacterial infections
#746USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
#747Fluorescent substrates for determining lysine modifying enzyme activity
#748Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging
#749Cell Free CD4 Quantitation and Methods of Use
#750PSA PEPTIDASE ACTIVITY (PPA) AS A PROSTATE CANCER BIOMARKER
#751SRM/MRM assay for the insulin receptor protein
#752METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES
#753METHOD FOR DOSING THE CONTROL CAPACITY OF C1INH
#754QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#755Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling
#756Systems And Methods For Detecting Scalp Follicular Inflammation In Humans
#757ICE INHIBITING COMPOUNDS AND USES THEREOF
#758Modified antibiotic peptides having variable systemic release
#759Methods of Screening for Inhibitors of Enzymes
#760Method for detecting the presence of the viable cells in an endodontic sample
#761Biomarker for abdominal aortic aneurysm
#762Mutant protease biosensors with enhanced detection characteristics
#763Magnetic-nanoparticle conjugates and methods of use
#764Enzyme treatment apparatus for proteins using a hollow fiber membrane, and on-line proteomics method using same
#765A-FUCOSYLATION DETECTION IN ANTIBODIES
#766Endoglycosidase from and methods using it
#767Mutant protease biosensors with enhanced detection characteristics
#768Selective glycosidase inhibitors and uses thereof
#769Kit For Sampling And Detection Of Endotoxin In Aqueous Solution
#770Glutamate oxidase mutagenesis for diagnostic testing
#771FUNCTION AND REGULATION OF ADAMTS-1
#772GINGIPAIN INHIBITORY PROPEPTIDES
#773Diagnosis, Prevention and Treatment of Disorders Characterized by Undesirable Cell Proliferation
#774Tau protease compositions and methods of use
#775Selective glycosidase inhibitors and uses thereof
#776Methods, compositions, and kits for detection of aspergillosis
#777FRET based multiplex probes
#778METHODS OF MEASURING CELL VIABILITY IN TISSUE ENGINEERED PRODUCTS
#779SYSTEMS AND METHODS FOR ANALYZING ANIMAL FEED
#780Assay for clostridium botulinum neurotoxin
#781Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#782Method for fabricating stable-isotope-labeled target peptide fragment in mass spectrometry
#783Methods, compositions, and kits for detecting protease activity in complex samples
#784Methods and kits for detecting cardiac remodeling in subjects without clinical signs of heart failure
#785Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A
#786Quantification of vaccine compositions
#787Treatments for
#788METHODS AND COMPOSITIONS FOR DETECTING PLANT EXPOSURE TO PLANT PATHOGENS
#789Analytical method for fab and fab′ molecules
#790Protease-resistant systems for polypeptide display and methods of making and using thereof
#791Fluorogenic peptidase substrate
#792Fructosyl peptide oxidase
#793Compositions and methods for toxigenicity testing
#794Methods and products for in vivo enzyme profiling
#795Methods and compositions for reducing amyloid beta levels
#796Enzymatic cleavage based lateral flow assays
#797Method for determining the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system (variations), a device for realizing same and a method for diagnosing the defects in the hemostatic system on the basis of a change in the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system
#798Determination of direct thrombin inhibitors in fluids like serum or urine
#799Ubiquitin chain analysis
#800Ultrasensitive detection of beta hemolytic
#801Screening for protein variants using mass spectrometry
#802Method for quantification of allergens
#803Methods and kits for detecting mastitis
#804Plasminogen and plasmin variants
#805Methods and compositions for enhancing proteasome activity
#806MARKERS FOR EARLY DIAGNOSIS OF OVARIAN CANCER, MONITORING DURING THERAPY, AND NEW THERAPY OPTIONS DURING AND AFTER CHEMOTHERAPY
#807Methods for selecting protease resistant polypeptides
#808Methods and compositions for detecting and modulating O-glycosylation
#809SYSTEMATIC EVALUATION OF SEQUENCE AND ACTIVITY RELATIONSHIPS USING SITE EVALUATION LIBRARIES FOR ENGINEERING MULTIPLE PROPERTIES
#810METHOD FOR INHIBITING PROTEASE IN BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENTS
#811Method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme
#812Method of neonatal serological diagnosis
#813Method for separating peptides and proteins
#814Compositions and methods related to tauopathy
#815Compositions comprising enzyme-cleavable oxycodone prodrug
#816Immobilized enzymatic reactor
#817Method for the detection of enzymatic activity with magnetically functionalized substrates
#818Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
#819Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor
#820Assays for detecting enzymatic activity
#821Lamin A, An Activator of Longevity/Anti-Aging SIRT1 Protein
#822System and method for detecting and monitoring proteolysis of protein matrices
#823PSA ENZYMATIC ACTIVITY: A NEW BIOMARKER FOR ASSESSING PROSTATE CANCER AGGRESSIVENESS
#824Screening methods for identifying proteases inhibitors
#825MASP-2, a complement fixing enzyme, and uses for it
#826Azoline compound and azole compound library and method for producing same
#827SUPRAMOLECULAR NANOBEACON IMAGING AGENTS AS PROTEASE SENSORS
#828Liquid processing system and liquid processing method
#829Methods of measuring protein and/or fat digestibility and uses thereof
#830FLUORESCENCE LIFETIME EPIGENETICS ASSAYS
#831Treatment of chronic pelvic pain syndrome
#832Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
#833Analysis of amino acid copolymer compositions
#834Destructible surfactants and uses thereof
#835METHOD FOR DETECTING MICROORGANISMS
#836Compositions and methods for the treatment of tissue fibrosis
#837Wound prognosis
#838GLUTAMYL AMINOPEPTIDASE AS A MARKER OF RENAL DAMAGE
#839Evaluation of copolymer diethylamide
#840Method for screening inhibitory substances to inflammatory skin-aging
#841Method and apparatus for fractionation-based chemical analyses
#842Purification of cell culture derived alphaprotease inhibitor
#843Methods and compositions for gamma-secretase assay
#844Mutant protease biosensors with enhanced detection characteristics
#845Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes
#846MONITORING OF WOUNDS BY MEASUREMENT OF PROTEASE AND PROTEASE INHIBITOR LEVELS IN WOUND FLUIDS
#847Methods and compounds for increasing sensitivity of botulinum assays
#848METHOD AND REAGENTS FOR TREATING HEPATIC FIBROSIS AND INFLAMMATION
#849System for the assessment of protease activity
#850Fitness assay and associated methods
#851Detection of protease and protease activity using a single nanocrescent SERS probe
#852Method for the determination of botulinum neurotoxin biological activity
#853Quantitation of GCP activity in biological samples
#854ANTIMICROBIAL AGENTS
#855Chemiluminescence-based haemostasis assay
#856Enhancing endotoxin detection
#857Method for using an enzyme resistant to high pressures
#858Nitrated cardiac troponin I as a biomarker of cardiac ischemia
#859Copolymer-1, process for preparation and analytical methods thereof
#860Ice-cleaved alpha-synuclein as a biomarker
#861Truncated HER2 SRM/MRM assay
#862Methods of generating and screening for lytic chimeric polypeptides
#863Screening method using gelatinase-mediated EphA4 cleavage reaction as an indicator
#864Detection of degradative enzymes and biomolecules in bodily fluids
#865Methods of screening an agent for an activity in an isolated eye of a teleost
#866Engineered conformationally-stabilized proteins
#867IDENTIFICATION OF MODULATORS OF SERINE PROTEASE INHIBITOR KAZAL AND THEIR USE AS ANTI-CANCER AND ANTI-VIRAL AGENTS
#868COMPOSITION FOR TREATING BLOOD AND SET OF DIAGNOSTIC KIT COMPRISING THE SAME TO DETECT AUTOIMMUNE DISEASE
#869Plasminogen and plasmin variants
#870GREEN TEA POLYPHENOL ALPHA SECRETASE ENHANCERS AND METHODS OF USE
#871Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin
#872Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells
#873Protease degradable polypeptides and uses thereof
#874Detecting infection in reduced pressure wound treatment
#875Measurement method using enzyme
#876Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus
#877Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof
#878Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#879Markers of Endothelial Progenitor Cells and Uses Thereof
#880Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
#881PROTEASE FOR PROTEOMICS
#882Ultrasensitive cell based sensors and uses thereof
#883Methods and compositions for the treatment of symptoms of prion diseases
#884Assays for detection of glycosaminoglycans
#885Linked peptide fluorogenic biosensors
#886Protease screening methods and proteases identified thereby
#887System and methods of log-scale concentration gradients
#888METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#889METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#890NOVEL METHOD FOR CHARACTERIZING AND MULTI-DIMENSIONALLY REPRESENTING THE FOLDING PROCESS OF PROTEINS
#891Ubiquitination assay
#892Method for measuring glycated hemoglobin
#893FGL-2 prothrombinase as a diagnostic tool for malignancy
#894USP2a peptides and antibodies
#895Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease
#896Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides
#897Analysis of amino acid copolymer compositions
#898Resonance energy transfer assay with cleavage sequence and spacer
#899METHODS OF DETECTING PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2)
#900METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME